The Gross Margin of HLS Therapeutics Inc (HLS.TO) is 84.11%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 84.11% |
| 2023-12-31 | 87.91% |
| 2022-12-31 | 91.87% |
| 2021-12-31 | 93.33% |
| 2020-12-31 | 93.58% |
| 2019-12-31 | 96.31% |
| 2018-12-31 | 95.77% |
| 2017-12-31 | 94.41% |